Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Jui Ho

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancerClemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg, et al.
Nature Cancer|February 4, 2022
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinomaAkimasa Hayashi, Jun Fan, Ruoyao Chen, et al.
Nature|August 17, 2022
Ordered and deterministic cancer genome evolution after p53 lossTimour Baslan, John P Morris, Zhen Zhao, et al.
Journal of Hepatology|March 13, 2026
An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinomaMariana Nogueira Batista, Juliano Bordignon, Ana Luiza Pamplona Mosimann, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Cancer Cell|June 20, 2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic CancerLuisa F Escobar-Hoyos, Alex Penson, Ram Kannan, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancerClemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg, et al.
Nature Cancer|February 4, 2022
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinomaAkimasa Hayashi, Jun Fan, Ruoyao Chen, et al.
Nature|August 17, 2022
Ordered and deterministic cancer genome evolution after p53 lossTimour Baslan, John P Morris, Zhen Zhao, et al.
Journal of Hepatology|March 13, 2026
An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinomaMariana Nogueira Batista, Juliano Bordignon, Ana Luiza Pamplona Mosimann, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Cancer Cell|June 20, 2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic CancerLuisa F Escobar-Hoyos, Alex Penson, Ram Kannan, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Pageof 7